ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,665Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 807

$667K Total Retail Price of All Prescriptions

Rank: 44 out of 807

609 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 609 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 609 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 10,536 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
AMLODIPINE BESYLATE 655 622 1 5
SIMVASTATIN 514 503 2 1
LEVOTHYROXINE SODIUM 436 421 3 3
LISINOPRIL 347 306 4 2
METOPROLOL SUCCINATE 316 314 5 13
ATORVASTATIN CALCIUM 309 274 6 11
ATENOLOL 299 281 7 7
WARFARIN SODIUM 282 275 8 10
FUROSEMIDE 268 260 9 6
HYDROCHLOROTHIAZIDE 265 253 10 9
METOPROLOL TARTRATE 237 224 11 8
OMEPRAZOLE 226 202 12 4
HYDROCODONE-ACETAMINOPHEN 214 197 S3 13 15
LOSARTAN POTASSIUM 203 195 14 14
GABAPENTIN 201 196 15 16
PRAVASTATIN SODIUM 193 178 16 21
METFORMIN HCL 189 175 17 12
POTASSIUM CHLORIDE 168 161 18 18
SPIRONOLACTONE 135 125 19 48
ZOLPIDEM TARTRATE 129 111 20 23
PANTOPRAZOLE SODIUM 127 113 21 44
ALLOPURINOL 120 110 22 26
TRAMADOL HCL 118 116 23 19
TRIAMTERENE-HCTZ 118 115 23 29
RANITIDINE HCL 116 102 25 34
CITALOPRAM HBR 105 105 26 17
KLOR-CON 10 103 103 27 81
PREDNISONE 103 103 27 24
TORSEMIDE 98 95 29 106
ALENDRONATE SODIUM 97 88 30 20
SERTRALINE HCL 97 93 30 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 93 32 28
SPIRIVA 87 87 33 50
CRESTOR 86 86 34 32
LIPITOR 83 68 35 100
OXYCODONE HCL 81 35 S2 36 53
TAMSULOSIN HCL 74 64 37 27
TRAZODONE HCL 71 55 38 25
ADVAIR DISKUS 71 57 38 33
LOSARTAN-HYDROCHLOROTHIAZIDE 69 68 40 55
METFORMIN HCL ER 68 54 41 61
ISOSORBIDE MONONITRATE ER 67 65 42 36
LANTUS SOLOSTAR 59 52 43 42
AZITHROMYCIN 59 57 43 57
CARVEDILOL 59 52 43 35
BYSTOLIC 58 40 46 150
PAROXETINE HCL 58 51 46 49
TEMAZEPAM 57 42 48 314
GLIPIZIDE 55 54 49 58
LOVASTATIN 54 49 50 39
GLIMEPIRIDE 53 41 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.